December 13, 2017 Prevalence of overweight, obesity, abdominal obesity and obesity-related risk factors in southern China. PLoS One. 2017;12:e0183934
Hu L, Huang X, You C, Li J, Hong K, Li P, Wu Y, Wu Q, Wang Z, Gao R, Bao H, Cheng X
December 13, 2017 The influence of physical activity on risk of cardiovascular disease in people who are obese but metabolically healthy. PLoS One. 2017;12:e0185127
Moon S, Oh CM, Choi MK, Park YK, Chun S, Choi M, Yu JM, Yoo HJ
December 12, 2017 Secondary prevention of cardiovascular disease in patients with type 2 diabetes mellitus: International insights from the TECOS trial (Trial Evaluating Cardiovascular Outcomes With Sitagliptin). Circulation. 2017;136:1193-1203
Pagidipati NJ, Navar AM, Pieper KS, Green JB, Bethel MA, Armstrong PW, Josse RG, McGuire DK, Lokhnygina Y, Cornel JH, Halvorsen S, Strandberg TE, Delibasi T, Holman RR, Peterson ED; TECOS Study Group
December 12, 2017 Diabetes mellitus and control of cardiovascular disease risk factors: A challenge to improve usual care. Circulation. 2017;136:1204-1206
Wilson PWF, Gagnon D
Keep up with all the latest from the cardiometabolic world. For breaking news, website updates and exclusive invitations to events with your peers.
No upcoming event.
Expert Opinions What is the role of lifestyle factors on brain health?
Louis Bherer, PhD, Chair in Preventive Health Science Research and Scientific Director of the PERFORM Centre, Concordia University, Montréal, QC, Canada
Expert Opinions Why do you think there is still a gap between what we know about the science of obesity as a health hazard and our public health messages still referring to weight loss and healthy BMI?
Lise Gauvin, PhD, Professor, Department of Social and Preventive Medicine, Université de Montréal; Associate Scientific Director for Population Health Research, CHUM Research Centre, Montréal, QC, Canada
Expert Opinions Considering the epidemic of physical inactivity, do you think that the recommended level of physical activity in the current guidelines is sufficient or optimal?
Jonathan Myers, PhD, FACC, FACSM, FAACVPR, FAHA, Health Research Scientist, VA Palo Alto Health Care System; Clinical Professor of Medicine, Stanford University, Palo Alto, CA, USA
In the Spotlight
Expert Opinions What are the remaining challenges and barriers to overcome in order to improve cardiovascular health worldwide?
Philip J. Barter, MD, MBBS, FRACP, PhD, Conjoint Professor, University of New South Wales, Sydney, Australia
Luc Van Gaal, MD, PhD, Professor of Medicine, Antwerp University Hospital, Faculty of Medicine, Department of Diabetology, Metabolism & Clinical Nutrition, Antwerp, Belgium
The International Chair on Cardiometabolic Risk